CLASS II Device recall · Reported 19 Apr 2017 · FDA Enforcement Report

Delta XL recalled by Draegar Medical Systems

Draegar Medical Systems is recalling Delta XL, distributed nationwide in the US. The recall was initiated on 28 Mar 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVF10.0 software
Quantity recalled2,156 (total for all devices)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1773-2017
FDA event ID
76862
Recalling firm
Draegar Medical Systems, Andover, MA
Classification
Class II
Status
Terminated
Recall initiated
28 Mar 2017
FDA classified
10 Apr 2017
Reported
19 Apr 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Patient Monitors

Timeline

28 Mar 2017Recall initiated by company
10 Apr 2017Classified by FDA+13 days
19 Apr 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

It was reported that a set low O2 alarm does not go off although the measured O2 level is below the alarm limit.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Delta XL, Catalog Number: MS18596 in combination with Scio, Scio Four, Scio Four Oxi plus, Scio Four Oxi, Scio Four plus. Product Usage: The devices are intended to be used in the environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patients medical condition. The Infinity Delta Series (Delta/Delta XL/Kappa) monitors are intended to be used on adult, pediatric, and neonatal populations, with the exception of the parameter Cardiac Output, ST Segment Analysis, and arrhythmia which are intended for use in the adult and pediatric populations only; and tcpO2, which for the neonatal population, is to only be used when the patient is not under gas anesthesia. For combination with Scio gas module: Scio gas module samples breathing gases from adults and pediatrics. The gas module continuously measure the content of CO2, N2O, O2 and one of the anesthetic agents, Halothane, Isoflurane, Enflurane, Sevoflurane and Desflurane in any mixture and communicates real time and derived gas information to the In-finity monitors.

Where it was distributed

Worldwide - US Nationwide distribution in the states of: AL, CA, GA, IL, LA, MA NY, OH, PA, TN, TX and VA and the countries of: AR AT BE BG BN BO BY CA CH CL CO CZ DE EG ES FI FR GB GR HR HU ID IE IL IN IT LT MX MY NL NO NP PA PE PK PL PT RO RS RU SA SE SK TH TR TW UG UZ VN ZA

Nationwide AlabamaArkansasCaliforniaColoradoGeorgiaIllinoisLouisianaMassachusettsNew YorkOhioPennsylvaniaTennesseeTexasVirginia

Questions about this recall

Is Delta XL recalled?

Yes. Draegar Medical Systems recalled Delta XL on 28 Mar 2017. The recall is Class II and its status is Terminated. Recall number Z-1773-2017.

Why was it recalled?

It was reported that a set low O2 alarm does not go off although the measured O2 level is below the alarm limit.

Which lots are affected?

VF10.0 software

Where was it sold?

Worldwide - US Nationwide distribution in the states of: AL, CA, GA, IL, LA, MA NY, OH, PA, TN, TX and VA and the countries of: AR AT BE BG BN BO BY CA CH CL CO CZ DE EG ES FI FR GB GR HR HU ID IE IL IN IT LT MX MY NL NO NP PA PE PK PL PT RO RS RU SA SE SK TH TR TW UG UZ VN ZA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Draegar Medical Systems

All 13

Other Patient Monitors recalls

All 1,013